Plaintiffs v. Boehringer Ingelheim (Pradaxa Litigation) (2014) iCONECT used by the law firm of Schlichter, Bogard & Denton
At the time of its 2010 approval, blood-thinner Pradaxa had no available antidote. It was responsible for serious bleeding events, including death in thousands of patients, with the argument being that Boehringer used deceptive marketing practices to promote its new category of anticoagulant. In 2014, the company settled 4,000 lawsuits for $650 million and the company was required to pay $95 million to settle a case over improper marketing.
Plaintiffs v. Bayer Healthcare Pharmaceuticals (2011) CONECT platform iCONECT platform used by the law firm of Schlichter, Bogard, Bogard & Denton
1,300 cases / plaintiffs in a MDL Litigation against Bayer claiming its Yasmin lin of birth-control pills caused blood clots in women. Bayer AG (BAYRY) said settlements of U.S. lawsuits over claims that its Yasmin line of birth-control pills caused blood clots have increased to more than $402 million.